The first two projects at the Wayne, Pennsylvania facility were on vaccines, Magdalena Mejillano, vice president of cGMP (current good manufacturing practice) lab services at PPD, told Outsourcing-Pharma.
Consequently, although the site was established to work on a range of therapeutics, PPD benefited immediately from co-locating the laboratory and vaccine centre of excellence.
PPD is also hoping to expand its formulation development and clinical trial material production collaboration with Bend Research. Particle size engineering technology at Bend could benefit inhalation clients, said Mejillano, and consequently PPD is hoping to expand this area of the deal.